Physician

Bettaiah T Gowda, M.D.

According to 2025 Medicare claims, Bettaiah Gowda, M.D. (NPI: 1962491225) practices gastroenterology in the Davenport-Moline-Rock Island, IA-IL market, with the plurality of this provider's patient population coming from Rock Island, IL. This provider's primary affiliated billing organization is GASTROINTESTINAL CLINIC OF QUAD CITIES, P.C. (NPI: 1942380605; TIN: 421168366) and primary practice location at 61265-6867. Gowda is affiliated with the Genesis Accountable Care Organization, LLC. (ACO ID: A4799), participating under the MSSP model.

Gowda's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 541 traditional Medicare patients, billed 3,074 HCPCS/CPT codes, and received $156,882 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,859 prescription claims across 496 beneficiaries totaling $302,499 in drug costs, led by Dupixent Pen (Dupilumab). 2018 DME data shows 33 claims. Open Payments data shows 9 records totaling $182. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $218,526 to $156,882. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $578,687 and ending at $302,499. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	945	2,113	$218,526
2016	898	1,858	$176,659
2017	773	2,138	$184,549
2018	693	1,942	$151,725
2019	645	1,739	$137,180
2020	590	1,356	$109,373
2021	574	1,312	$132,814
2022	591	1,908	$133,387
2023	590	2,605	$140,554
2024	541	3,074	$156,882

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	346	1,870	$578,687
2016	353	1,745	$324,524
2017	317	1,330	$315,279
2018	285	1,121	$435,370
2019	251	1,148	$218,211
2020	334	1,485	$205,231
2021	411	1,834	$507,833
2022	476	2,050	$467,826
2023	482	1,963	$323,040
2024	496	1,859	$302,499

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	49	$3,420
2016	N/R	35	$1,548
2017	N/R	33	$1,613
2018	N/R	33	$1,492
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	136	136	$193
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	148	178	$88
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	165	185	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	119	130	$61
88305	Pathology examination of tissue using a microscope, intermediate complexity	273	694	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Pen	Dupilumab	11	308	$84,180
Linzess	Linaclotide	61	2,850	$51,086
Sucralfate	Sucralfate	119	4,024	$18,445
Mesalamine	Mesalamine	48	2,460	$17,301
Dexlansoprazole Dr	Dexlansoprazole	56	2,530	$12,751

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$182	Mauna Kea Technologies, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bettaiah T. Gowda, M.D.?

Tedicare shows public-source Medicare data for Bettaiah T. Gowda, M.D. (NPI 1962491225), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bettaiah T. Gowda, M.D. have ACO affiliation data?

Bettaiah T. Gowda, M.D. is shown with ACO affiliation data for Genesis Accountable Care Organization, LLC. (MSSP, ACO ID A4799).

What billing organization is linked to Bettaiah T. Gowda, M.D.?

Bettaiah T. Gowda, M.D. is linked to GASTROINTESTINAL CLINIC OF QUAD CITIES, P.C. (billing NPI 1942380605) in the available physician profile data.

Does Bettaiah T. Gowda, M.D. have Open Payments data?

Bettaiah T. Gowda, M.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.